NUVL Nuvalent, Inc.
Healthcare$104.95+2.77%ClosedMarket Cap: $7.72B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
6.84
P/S
0.00
EV/EBITDA
-20.28
DCF Value
$3.22
FCF Yield
-4.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-42.8%
ROA
-33.8%
ROIC
-35.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-119.4M | $-109.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-102.2M | $-118.7M | $— | — |
| FY null | $0.00 | NaN% | $-414.3M | $-425.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-112.7M | $-122.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-104.6M | $-99.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-94.8M | $-84.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-86.3M | $-74.8M | $— | — |
| FY null | $0.00 | NaN% | $-280.4M | $-260.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-76.3M | $-84.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-65.2M | $-57.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-52.6M | $-44.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-46.4M | $-38.3M | $-0.62 | — |